CAS No.71731-58-3,Tiquizium bromide Suppliers

Products Categories

Pharmaceutical (43)
Others (9)
Organic Chemicals (7)
Reagent (2)
Basic Inorganic Chemicals (2)
Materials (1)

Basic Information

Molecular Structure:
CAS No.:	71731-58-3
Name:	Tiquizium bromide
Article Data:	1

Formula:	C19H24 N S2 . Br
Molecular Weight:	410.442
Synonyms:	2H-Quinolizinium,3-(di-2-thienylmethylene)octahydro-5-methyl-, bromide, (5R,9aR)-rel- (9CI);2H-Quinolizinium, 3-(di-2-thienylmethylene)octahydro-5-methyl-, bromide,trans-; HS 902; HSR 902; Thiaton; Tiquizium bromide
EINECS:	1312995-182-4
Melting Point:	278-281° (dec)
Safety:	Poison by subcutaneous, intravenous and intraperitoneal routes. Moderately toxic by ingestion. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of Br⁻, NO_x, and SO_x.
PSA:	56.48000
LogP:	2.36720

Total:54 Page 1 of 2 1 2 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 71731-58-3

Chemistry

IUPAC Name:(5R,9aR)-7-(dithiophen-2-ylmethylidene)-5-methyl-1,2,3,4,6,8,9,9a-
octahydroquinolizin-5-ium bromide(71731-58-3)
Synonyms: Tiquizium bromide ; (5R,9aR)-7-(dithiophen-2-ylmethylidene)-5-methyl-1,2,3,4,6,8,9,9a-octahydroquinolizin-5-ium bromide ; Tiquizium ; 2H-Quinolizinium, 3-(di-2-thienylmethylene)octahydro-5-methyl-, bromide, (5R,9aR)-rel- (9CI) ; 2H-Quinolizinium, 3-(di-2-thienylmethylene)octahydro-5-methyl-, bromide, trans- ; HS 902;HSR 902 ; Thiaton
CAS:71731-58-3
MF: C₁₉H₂₄BrNS₂
MW: 410.43
Mol File: 71731-58-3.mol
Melting point :246 ~ 248 ℃
Appearance: Tiquizium bromide (71731-58-3) is prism crystals.

Uses

1.Tiquizium bromide (71731-58-3) is antispasmodic, which can be obtained from 2 - hydroxyethyl-pyridine of the raw material;
2.Tiquizium bromide (71731-58-3) have good effects on spasm, gastric secretion inhibition and anti-ulcer caused by anti-acetylcholine of parasympathetic nerve endings.

Toxicity Data With Reference

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
dog	ld50	intraperitoneal	56700ug/kg (56.7mg/kg)	sense organs and special senses: mydriasis (pupillary dilation): eye behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: dyspnea	oyo yakuri. pharmacometrics. vol. 23, pg. 1, 1982.
dog	ld50	intravenous	14200ug/kg (14.2mg/kg)	sense organs and special senses: mydriasis (pupillary dilation): eye behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: dyspnea	oyo yakuri. pharmacometrics. vol. 23, pg. 1, 1982.
dog	ld50	oral	662mg/kg (662mg/kg)	sense organs and special senses: mydriasis (pupillary dilation): eye behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: dyspnea	oyo yakuri. pharmacometrics. vol. 23, pg. 1, 1982.
dog	ld50	subcutaneous	129mg/kg (129mg/kg)	sense organs and special senses: mydriasis (pupillary dilation): eye lungs, thorax, or respiration: dyspnea behavioral: convulsions or effect on seizure threshold	oyo yakuri. pharmacometrics. vol. 23, pg. 1, 1982.
mouse	ld50	intraperitoneal	83700ug/kg (83.7mg/kg)	sense organs and special senses: mydriasis (pupillary dilation): eye behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: dyspnea	oyo yakuri. pharmacometrics. vol. 23, pg. 1, 1982.
mouse	ld50	intravenous	10300ug/kg (10.3mg/kg)	sense organs and special senses: mydriasis (pupillary dilation): eye lungs, thorax, or respiration: dyspnea behavioral: convulsions or effect on seizure threshold	oyo yakuri. pharmacometrics. vol. 23, pg. 1, 1982.
mouse	ld50	oral	578mg/kg (578mg/kg)	sense organs and special senses: mydriasis (pupillary dilation): eye behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: dyspnea	oyo yakuri. pharmacometrics. vol. 23, pg. 1, 1982.
mouse	ld50	subcutaneous	82100ug/kg (82.1mg/kg)	sense organs and special senses: mydriasis (pupillary dilation): eye lungs, thorax, or respiration: dyspnea behavioral: convulsions or effect on seizure threshold	oyo yakuri. pharmacometrics. vol. 23, pg. 1, 1982.
rat	ld50	intraperitoneal	70500ug/kg (70.5mg/kg)	sense organs and special senses: mydriasis (pupillary dilation): eye behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: dyspnea	oyo yakuri. pharmacometrics. vol. 23, pg. 1, 1982.
rat	ld50	intravenous	11400ug/kg (11.4mg/kg)	sense organs and special senses: mydriasis (pupillary dilation): eye behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: dyspnea	oyo yakuri. pharmacometrics. vol. 23, pg. 1, 1982.
rat	ld50	oral	1177mg/kg (1177mg/kg)	sense organs and special senses: mydriasis (pupillary dilation): eye behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: dyspnea	oyo yakuri. pharmacometrics. vol. 23, pg. 1, 1982.
rat	ld50	subcutaneous	169mg/kg (169mg/kg)	sense organs and special senses: mydriasis (pupillary dilation): eye behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: dyspnea	oyo yakuri. pharmacometrics. vol. 23, pg. 1, 1982.

Safety Profile

Poison by subcutaneous, intravenous and intraperitoneal routes. Moderately toxic by ingestion. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of Br⁻, NO_x, and SO_x.